Check-Cap Ltd. - CHEK Company Long-Term Liabilities

Check-Cap Ltd. (CHEK) develops innovative video capsules for X-ray bowel examinations without prior cleansing, which simplifies the detection of oncology. The asset value tracked on the GURU.Markets chart currently stands at 0.00. Demand for such tests is independent of economic cycles or seasonality. Despite its Israeli origin and logistical challenges, the business minimizes risks through US patents.

CHEK (Check-Cap Ltd.) Company Long-Term Debt history from 07/04/2022 to 11/28/2025

Check-Cap (CHEK) - metric breakdowns and financial figures

- price and consensus price forecast:

Share Price Check-Cap Ltd|CHEK - Analyst Consensus Forecast

- market capitalization data:

Market Valuation Check-Cap|CHEK - Enterprise Value

- book capitalization data:

Net Asset Value per Share Check-Cap|CHEK - Company Book Value|Market Value to Book Value check-cap.com|CHEK - Cumulative Company Assets

- debt and liquidity data:

Initial company analysis:CHEK (Check-Cap Ltd.)

For Check-Cap Ltd. (CHEK), which is developing non-invasive colorectal cancer diagnostics, the company's level of long-term debt reflects the volume of capital raised for years ahead to commercialize X-ray systems. This metric aggregates all liabilities with maturities exceeding twelve months, allowing investors to assess the issuer's debt load and financial stability during the period of zero operating revenue.

Who Check-Cap Ltd. competes with

Company Long-Term Indebtedness carislifesciences.com CAI|GH: Company Long-Term Debts|VCYT - Company Long-Term Liabilities|Company Long-Term Debts CELC|GRAL (GRAIL Bio) - Long-Term Debt|MYGN - Company Long-Term Debt|Company Long-Term Loans and Borrowings castlebiosciences.com (CSTL)|Burning Rock (BNR) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings volition.com (VNRX)|Company Long-Term Debts BDSX (Biodesix Corp)|Precipio Inc - Company Long-Term Debts|Mainz Biomed N.V. (MYNZ) - Company Long-Term Debt|OCX - Company Long-Term Indebtedness